|
|
|
Schizophrenia Clinical Trials, Diagnosis, and Treatment |
|
Thank you for your interest in clinical trials for Schizophrenia.
Please click "Search" to find Schizophrenia clinical trials and medical research studies or read below for information on Schizophrenia diagnosis and treatment.
If you receive too many study listings you may enter your zip code to find the locations closest to you.
|
|
|
|
|
Results from Clinical Connection:
|
|
|
|
Your search returned 4 studies:
|
|
|
|
|
Results from other databases:
|
|
Your search returned over 250 results. The top 250 results are being displayed. Please use additional keywords or decrease the search distance. |
|
Your search returned 250 studies:
- A Dose-Response Study of Modafinil Effects on Cognition in Healthy Adults and in Schizophrenia Patients - NCT00711464-95817
Conditions: Schizophrenia Location: Sacramento, CA
- A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence - NCT00737256-80220
Conditions: Schizophrenia - Cocaine Dependence Location: Denver, CO
- A Multiple Dose Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-288 in Stable Subjects With Schizophrenia - NCT00888693-91206
Conditions: Schizophrenia Location: Glendale, CA
- A Patient-Centered Approach to Improve Screening for Side Effects of Second Generation Antipsychotics (SGAs) - NCT00677898-21201
Conditions: Schizophrenia - Psychotic Disorders Location: Baltimore, MD
- A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients. - NCT00845026-08046
Conditions: Schizophrenia Location: Willingboro, NJ
- A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients. - NCT00845026-11701
Conditions: Schizophrenia Location: Amityville, NY
- A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients. - NCT00845026-20016
Conditions: Schizophrenia Location: Washington, DC
- A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients. - NCT00845026-46222
Conditions: Schizophrenia Location: Indianapolis, IN
- A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients. - NCT00845026-60194
Conditions: Schizophrenia Location: Hoffman Estates, IL
- A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients. - NCT00845026-60640
Conditions: Schizophrenia Location: Chicago, IL
- A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients. - NCT00845026-70601
Conditions: Schizophrenia Location: Lake Charles, LA
- A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients. - NCT00845026-73103
Conditions: Schizophrenia Location: Oklahoma City, OK
- A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients. - NCT00845026-75115
Conditions: Schizophrenia Location: Desoto, TX
- A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients. - NCT00845026-92025
Conditions: Schizophrenia Location: Escondido, CA
- A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients. - NCT00845026-92845
Conditions: Schizophrenia Location: Garden Grove, CA
- A Single-Center, Double-Blind (DB) Study of MEM 3454 on P50 Sensory Gating and Mismatch Negativity in Schizophrenia Patients - NCT00725855-80262
Conditions: Schizophrenia Location: Denver, CO
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-08046
Conditions: Schizophrenia Location: Willingboro, NJ
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-11366
Conditions: Schizophrenia Location: Fresh Meadows, NY
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-11423
Conditions: Schizophrenia Location: Holliswood, NY
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-19139
Conditions: Schizophrenia Location: Philadelphia, PA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-20016
Conditions: Schizophrenia Location: Washington, DC
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-20036
Conditions: Schizophrenia Location: Washington, DC
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-30328
Conditions: Schizophrenia Location: Atlanta, GA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-30342
Conditions: Schizophrenia Location: Atlanta, GA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-60068
Conditions: Schizophrenia Location: Park Ridge, IL
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-67207
Conditions: Schizophrenia Location: Wichita, KS
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-67211
Conditions: Schizophrenia Location: Wichita, KS
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-77005
Conditions: Schizophrenia Location: Houston, TX
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-77008
Conditions: Schizophrenia Location: Houston, TX
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-90502
Conditions: Schizophrenia Location: Torrance, CA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-90703
Conditions: Schizophrenia Location: Cerritos, CA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-90805
Conditions: Schizophrenia Location: Long Beach, CA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-92845
Conditions: Schizophrenia Location: Garden Grove, CA
- A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia - NCT00621777-02114
Conditions: Schizophrenia - Schizoaffective Disorder - Smoking Location: Boston, MA
- A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia - NCT00621777-02130
Conditions: Schizophrenia - Schizoaffective Disorder - Smoking Location: Jamaica Plain, MA
- A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia - NCT00621777-03063
Conditions: Schizophrenia - Schizoaffective Disorder - Smoking Location: Nashua, NH
- A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia - NCT00621777-10612
Conditions: Schizophrenia - Schizoaffective Disorder - Smoking Location: Worcester, MA
- A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia - NCT00621777-49503
Conditions: Schizophrenia - Schizoaffective Disorder - Smoking Location: Grand Rapids, MI
- Addition of Ondansetron to Ongoing Antipsychotic Treatment for Schizophrenia - NCT00149734-80220
Conditions: Schizophrenia Location: Denver, CO
- Add-on Simvastatin in Schizophrenia Trial - NCT00605995-10032
Conditions: Schizophrenia Location: New York, NY
- Aripiprazole for Co-Morbid Schizophrenia and Cocaine Dependence - NCT00819689-80220
Conditions: Schizophrenia - Cocaine Dependence Location: Denver, CO
- Attention Shaping Procedures for Improving Psychosocial Skills Among Adults With Schizophrenia - NCT00391677-08852
Conditions: Schizophrenia Location: Monmouth Junction, NJ
- Attention Shaping Procedures for Improving Psychosocial Skills Among Adults With Schizophrenia - NCT00391677-08901
Conditions: Schizophrenia Location: New Brunswick, NJ
- Behavioral Treatment of Drug Abuse in Severe and Persistent Mental Illness (SPMI) Patients - NCT00295139-21201A
Conditions: Schizophrenia - Mood Disorders - Substance Dependence Location: Baltimore, MD
- Behavioral Treatment of Drug Abuse in Severe and Persistent Mental Illness (SPMI) Patients - NCT00295139-21201B
Conditions: Schizophrenia - Mood Disorders - Substance Dependence Location: Baltimore, MD
- Behavioral Treatment of Drug Abuse in Severe and Persistent Mental Illness (SPMI) Patients - NCT00295139-21201C
Conditions: Schizophrenia - Mood Disorders - Substance Dependence Location: Baltimore, MD
- Behavioral Treatment of Drug Abuse in Severe and Persistent Mental Illness (SPMI) Patients - NCT00295139-21228
Conditions: Schizophrenia - Mood Disorders - Substance Dependence Location: Catonsville, MD
- Biomarker Study of Acamprosate in Schizophrenia - NCT00688324-21201
Conditions: Schizophrenia - Schizoaffective Disorder Location: Baltimore, MD
- Biomarker Study of Acamprosate in Schizophrenia - NCT00688324-21222
Conditions: Schizophrenia - Schizoaffective Disorder Location: Baltimore, MD
- Biomarker Study of Acamprosate in Schizophrenia - NCT00688324-21228A
Conditions: Schizophrenia - Schizoaffective Disorder Location: Baltimore, MD
- Biomarker Study of Acamprosate in Schizophrenia - NCT00688324-21228B
Conditions: Schizophrenia - Schizoaffective Disorder Location: Baltimore, MD
- Biomarkers in Schizophrenia - NCT00817336-10962
Conditions: Schizophrenia - Schizoaffective Disorder Location: Orangeburg, NY
- Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes - NCT00666432-06106
Conditions: Schizophrenia - Bipolar Location: Hartford, CT
- Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes - NCT00666432-21201
Conditions: Schizophrenia - Bipolar Location: Baltimore, MD
- Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes - NCT00666432-21228
Conditions: Schizophrenia - Bipolar Location: Baltimore, MD
- Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes - NCT00666432-48201
Conditions: Schizophrenia - Bipolar Location: Detroit, MI
- Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes - NCT00666432-60612
Conditions: Schizophrenia - Bipolar Location: Chicago, IL
- Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes - NCT00666432-75390
Conditions: Schizophrenia - Bipolar Location: Dallas, TX
- Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine - NCT00312598-27599
Conditions: Schizophrenia - Schizoaffective Disorder - Schizophreniform Disorder - Mood Disorders Location: Chapel Hill, NC
- Brain Activation Patterns in Schizophrenia After Computerized Cognitive Skills Training - NCT00431223-10035
Conditions: Schizophrenia Location: New York, NY
- Brain Tissue Collection for Neuropathological Studies - NCT00001260-20003
Conditions: Bipolar Disorder - Depression - Anxiety Disorders - Schizophrenia - Tourette's Syndrome - Brain Diseases Location: Washington, DC
- Brain Tissue Collection for Neuropathological Studies - NCT00001260-20892
Conditions: Bipolar Disorder - Depression - Anxiety Disorders - Schizophrenia - Tourette's Syndrome - Brain Diseases Location: Bethesda, MD
- Brain Tissue Collection for Neuropathological Studies - NCT00001260-22032
Conditions: Bipolar Disorder - Depression - Anxiety Disorders - Schizophrenia - Tourette's Syndrome - Brain Diseases Location: Fairfax, VA
- Change in Brain Bioenergetics in Bipolar Disorder in Response to Photic Stimulation - NCT00801567-02478
Conditions: Bipolar Disorder - Schizophrenia - Healthy Controls Location: Belmont, MA
- Clinical Trial of Tolcapone for Cognition in Schizophrenia - NCT00044083-20892
Conditions: Schizophrenia Location: Bethesda, MD
- Cognitive Behavior Therapy and Work Outcome - NCT00810355-46202
Conditions: Schizophrenia Location: Indianapolis, IN
- Cognitive Therapy for Negative Symptoms and Functioning - NCT00350883-19104
Conditions: Schizophrenia - Schizoaffective Disorder Location: Philadelphia, PA
- Cognitive Training to Enhance VA Work Program Outcomes - NCT00829400-06516
Conditions: Mental Illness - Schizophrenia - Depression - PTSD - Bipolar Disorder Location: West Haven, CT
- Cognitive-Behavioral Therapy in Veterans With Schizophrenia - NCT00688259-90073
Conditions: Schizophrenia - Schizoaffective Disorder Location: West Los Angeles, CA
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-01605
Conditions: Schizophrenia - Schizoaffective Disorder Location: Worcester, MA
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-02114
Conditions: Schizophrenia - Schizoaffective Disorder Location: Boston, MA
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-02720
Conditions: Schizophrenia - Schizoaffective Disorder Location: Fall River, MA
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-06050
Conditions: Schizophrenia - Schizoaffective Disorder Location: Farmington, CT
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-06519
Conditions: Schizophrenia - Schizoaffective Disorder Location: New Haven, CT
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-10032
Conditions: Schizophrenia - Schizoaffective Disorder Location: New York, NY
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-14623
Conditions: Schizophrenia - Schizoaffective Disorder Location: Rochester, NY
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-19104
Conditions: Schizophrenia - Schizoaffective Disorder Location: Philadelphia, PA
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-19124
Conditions: Schizophrenia - Schizoaffective Disorder Location: Philadelphia, PA
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-21061
Conditions: Schizophrenia - Schizoaffective Disorder Location: Glen Burnie, MD
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-27509
Conditions: Schizophrenia - Schizoaffective Disorder Location: Butner, NC
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-27599
Conditions: Schizophrenia - Schizoaffective Disorder Location: Chapel Hill, NC
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-28211
Conditions: Schizophrenia - Schizoaffective Disorder Location: Charlotte, NC
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-30329
Conditions: Schizophrenia - Schizoaffective Disorder Location: Atlanta, GA
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-30912
Conditions: Schizophrenia - Schizoaffective Disorder Location: Augusta, GA
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-33316
Conditions: Schizophrenia - Schizoaffective Disorder Location: Miami, FL
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-33431
Conditions: Schizophrenia - Schizoaffective Disorder Location: Boca Raton, FL
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-45267
Conditions: Schizophrenia - Schizoaffective Disorder Location: Cincinnati, OH
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-48201
Conditions: Schizophrenia - Schizoaffective Disorder Location: Detroit, MI
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-52242
Conditions: Schizophrenia - Schizoaffective Disorder Location: Iowa City, IA
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-53227
Conditions: Schizophrenia - Schizoaffective Disorder Location: Milwaukee, WI
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-55454
Conditions: Schizophrenia - Schizoaffective Disorder Location: Minneapolis, MN
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-63110
Conditions: Schizophrenia - Schizoaffective Disorder Location: St. Louis, MO
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-67207
Conditions: Schizophrenia - Schizoaffective Disorder Location: Wichita, KS
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-71130
Conditions: Schizophrenia - Schizoaffective Disorder Location: Shreveport, LA
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-75235
Conditions: Schizophrenia - Schizoaffective Disorder Location: Dallas, TX
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-77030
Conditions: Schizophrenia - Schizoaffective Disorder Location: Houston, TX
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-77304
Conditions: Schizophrenia - Schizoaffective Disorder Location: Conroe, TX
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-78229
Conditions: Schizophrenia - Schizoaffective Disorder Location: San Antonio, TX
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-87108
Conditions: Schizophrenia - Schizoaffective Disorder Location: Albuquerque, NM
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-92093
Conditions: Schizophrenia - Schizoaffective Disorder Location: San Diego, CA
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-92324
Conditions: Schizophrenia - Schizoaffective Disorder Location: Colton, CA
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-92868
Conditions: Schizophrenia - Schizoaffective Disorder Location: Orange, CA
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-94305
Conditions: Schizophrenia - Schizoaffective Disorder Location: Palo Alto, CA
- Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - NCT00423878-98493
Conditions: Schizophrenia - Schizoaffective Disorder Location: Tacoma, WA
- Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis - NCT00320671-07018
Conditions: Schizophrenia Location: East Orange, NJ
- Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis - NCT00320671-10456
Conditions: Schizophrenia Location: Bronx, NY
- Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis - NCT00320671-11004
Conditions: Schizophrenia Location: Glen Oaks, NY
- Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis - NCT00320671-11030
Conditions: Schizophrenia Location: Manhasset, NY
- Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis - NCT00320671-11212
Conditions: Schizophrenia Location: Brooklyn, NY
- Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis - NCT00320671-11418
Conditions: Schizophrenia Location: Jamaica, NY
- Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis - NCT00320671-78229
Conditions: Schizophrenia Location: San Antonio, TX
- Comparison of Video Consent Versus Routine Consent for Participation in Research Studies - NCT00430391-92161
Conditions: Schizophrenia Location: San Diego, CA
- Contingency Management of Psychostimulant Abuse in the Severely Mentally Ill - NCT00809770-98104
Conditions: Drug Abuse - Schizophrenia - Bipolar Disorder - Major Depressive Disorder Location: Seattle, WA
- Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia - NCT00136760-02912
Conditions: Schizophrenia and Disorders With Psychotic Features - Tobacco Use Disorder Location: Providence, RI
- Contrasting the Brain Effects of Risperidone and Invega With Functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) Scanning - NCT00937261-92697
Conditions: Schizophrenia Location: Irvine, CA
- Coronary Artery Disease (CAD) Risk in Schizophrenia: Effect of Omega-3 Fatty Acid Supplementation - NCT00167310-15206
Conditions: Schizophrenia - Schizoaffective Disorder - Major Depression - Bipolar Disorder - Coronary Artery Disease Location: Pittsburgh, PA
- Culturally Based Family Therapy for Improving Treatment Outcome for People With Schizophrenia - NCT00356317-33146
Conditions: Schizophrenia Location: Coral Gables, FL
- D-cycloserine Augmentation of Cognitive Remediation in Schizophrenia - NCT00963924-02114
Conditions: Schizophrenia Location: Boston, MA
- Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia - NCT00690235-75390
Conditions: Schizophrenia - Schizoaffective Disorder - Diabetes - Weight Gain Location: Dallas, TX
- Determining Metabolic Effects of Valproate and Antipsychotic Therapy - NCT00167934-63110
Conditions: Schizophrenia Location: St. Louis, MO
- Direct Measurements of Cardiometabolic Risk in Treated Schizophrenia Patients - NCT00501163-63110
Conditions: Schizophrenia - Cardiovascular Disease Location: St. Louis, MO
- D-Serine for the Schizophrenia Prodrome - NCT00826202-
Conditions: Schizophrenia Prodrome Location: Glen Oaks, NY
- D-Serine for the Schizophrenia Prodrome - NCT00826202-10962
Conditions: Schizophrenia Prodrome Location: Orangeburg, NY
- Effect of Ziprasidone on Glucose & Plasma Lipids in Diabetes (II) and Schizophrenia or Schizoaffective Disorder - NCT00395031-10035
Conditions: Schizophrenia - Schizoaffective Disorder Location: New York, NY
- Effectiveness of a Lifestyle Intervention for Increasing Physical Activity in Adults With Schizophrenia - NCT00338832-92093
Conditions: Schizophrenia Location: La Jolla, CA
- Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia - NCT00158223-10029
Conditions: Schizophrenia - Psychotic Disorders Location: New York, NY
- Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia - NCT00158223-10035
Conditions: Schizophrenia - Psychotic Disorders Location: New York, NY
- Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia - NCT00158223-11717
Conditions: Schizophrenia - Psychotic Disorders Location: W. Brentwood, NY
- Effectiveness of Targeted Cognitive Training for Neurological Deficits in People With Schizophrenia - NCT00312962-94121
Conditions: Schizophrenia Location: San Francisco, CA
- Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia - NCT00435370-77030
Conditions: Smoking Cessation - Schizophrenia Location: Houston, TX
- Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia - NCT00611806-02114
Conditions: Schizophrenia Location: Boston, MA
- Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia - NCT00611806-14623
Conditions: Schizophrenia Location: Rochester, NY
- Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia - NCT00611806-49503
Conditions: Schizophrenia Location: Grand Rapids, MI
- Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective Disorder - NCT00373672-37212
Conditions: Schizophrenia - Schizoaffective Disorder Location: Nashville, TN
- Effects of Eszopiclone on Sleep-dependent Learning in Schizophrenia - NCT00833547-02114
Conditions: Schizophrenia Location: Boston, MA
- Effects of Modafinil on Brain Function in Patients With Schizophrenia - NCT00057707-20892
Conditions: Schizophrenia - Schizoaffective Disorder Location: Bethesda, MD
- Effects of Oxytocin Nasal Spray on Social Affiliation - NCT00663039-21228
Conditions: Schizophrenia Location: Catonsville, MD
- Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia - NCT00148083-10605
Conditions: Schizophrenia - Schizoaffective Disorder Location: White Plains, NY
- Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia - NCT00148083-60612
Conditions: Schizophrenia - Schizoaffective Disorder Location: Chicago, IL
- Effects of Smoking Cues on Tobacco Craving Responses and the Reinforcing Efficacy of Cigarettes in Smokers With and Without Schizophrenia - NCT00770237-21228
Conditions: Schizophrenia - Nicotine Dependence Location: Catonsville, MD
- Efficacy of Pregnenolone in Patients With Schizophrenia - NCT00615511-10065
Conditions: Schizophrenia - Schizoaffective Disorder Location: New York, NY
- Efficacy of Pregnenolone in Patients With Schizophrenia - NCT00615511-10605
Conditions: Schizophrenia - Schizoaffective Disorder Location: White Plains, NY
- Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms - NCT00922272-08046
Conditions: Schizophrenia and Predominant Negative Symptoms Location: Willingboro, NJ
- Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms - NCT00922272-10523
Conditions: Schizophrenia and Predominant Negative Symptoms Location: Elmsford, NY
- Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms - NCT00922272-11423
Conditions: Schizophrenia and Predominant Negative Symptoms Location: Holliswood, NY
- Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms - NCT00922272-34741
Conditions: Schizophrenia and Predominant Negative Symptoms Location: Kissimmee, FL
- Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms - NCT00922272-45219
Conditions: Schizophrenia and Predominant Negative Symptoms Location: Cincinnati, OH
- Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms - NCT00922272-75062
Conditions: Schizophrenia and Predominant Negative Symptoms Location: Irving, TX
- Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms - NCT00922272-78756
Conditions: Schizophrenia and Predominant Negative Symptoms Location: Austin, TX
- Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms - NCT00922272-90813
Conditions: Schizophrenia and Predominant Negative Symptoms Location: Long Beach, CA
- Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms - NCT00922272-92056
Conditions: Schizophrenia and Predominant Negative Symptoms Location: Oceanside, CA
- Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms - NCT00922272-92108
Conditions: Schizophrenia and Predominant Negative Symptoms Location: San Diego, CA
- Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms - NCT00922272-92845
Conditions: Schizophrenia and Predominant Negative Symptoms Location: Garden Grove, CA
- Electrophysiology and Blood Flow in Patients With Schizophrenia and Their Siblings - NCT00001921-20892
Conditions: Healthy - Schizophrenia Location: Bethesda, MD
- Enhancing Motivation To Quit Smoking In Smokers With Serious Mental Illness - NCT00500695-08901
Conditions: Schizophrenia - Schizoaffective Disorder Location: New Brunswick, NJ
- Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder - NCT00501618-10027
Conditions: Schizophrenia - Schizoaffective Disorder Location: New York, NY
- Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder - NCT00501618-10035
Conditions: Schizophrenia - Schizoaffective Disorder Location: New York, NY
- Evaluating Genetic Risk Factors for Childhood-Onset Schizophrenia - NCT00001198-20892
Conditions: Healthy - Schizophrenia Location: Bethesda, MD
- Examining Risk Factors for Atypical Antipsychotic Metabolic Side Effects - NCT00815854-48109
Conditions: Schizophrenia Location: Ann Arbor, MI
- Facilitation of NMDA Receptor Function in Patients With Schizophrenia and co-Morbid Alcoholism - NCT00338598-06516
Conditions: Alcoholism - Schizophrenia Location: West Haven, CT
- Family-Directed Cognitive Adaptation Program for Individuals With Schizophrenia - NCT00434980-02114
Conditions: Schizophrenia - Schizoaffective Disorder - Schizophreniform Disorder Location: Boston, MA
- Family-Directed Cognitive Adaptation Program for Individuals With Schizophrenia - NCT00434980-02130
Conditions: Schizophrenia - Schizoaffective Disorder - Schizophreniform Disorder Location: Jamaica Plain, MA
- Feasibility of Providing Cognitive Remediation to People With Schizophrenia in a Clinical Network - NCT00930150-01605
Conditions: Schizophrenia Location: Worcester, MA
- Feasibility of Providing Cognitive Remediation to People With Schizophrenia in a Clinical Network - NCT00930150-06519
Conditions: Schizophrenia Location: New Haven, CT
- Feasibility of Providing Cognitive Remediation to People With Schizophrenia in a Clinical Network - NCT00930150-19104
Conditions: Schizophrenia Location: Philadelphia, PA
- Feasibility of Providing Cognitive Remediation to People With Schizophrenia in a Clinical Network - NCT00930150-27599
Conditions: Schizophrenia Location: Chapel Hill, NC
- Feasibility of Providing Cognitive Remediation to People With Schizophrenia in a Clinical Network - NCT00930150-30329
Conditions: Schizophrenia Location: Atlanta, GA
- Feasibility of Providing Cognitive Remediation to People With Schizophrenia in a Clinical Network - NCT00930150-30912
Conditions: Schizophrenia Location: Augusta, GA
- Feasibility of Providing Cognitive Remediation to People With Schizophrenia in a Clinical Network - NCT00930150-52242
Conditions: Schizophrenia Location: Iowa City, IA
- Feasibility of Providing Cognitive Remediation to People With Schizophrenia in a Clinical Network - NCT00930150-55454
Conditions: Schizophrenia Location: Minneapolis, MN
- Feasibility of Providing Cognitive Remediation to People With Schizophrenia in a Clinical Network - NCT00930150-78229
Conditions: Schizophrenia Location: San Antonio, TX
- FMRI of Cholinergic Mechanisms in Schizophrenia - NCT00692679-80220
Conditions: Schizophrenia Location: DENVER, CO
- FMRI of Cholinergic Mechanisms in Schizophrenia - NCT00692679-80262
Conditions: Schizophrenia Location: DENVER, CO
- Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal - NCT00314613-27509
Conditions: Schizophrenia Location: Butner, NC
- Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal - NCT00314613-27710
Conditions: Schizophrenia Location: Durham, NC
- Functional Rehabilitation for Older Patients With Schizophrenia - NCT00712075-92161
Conditions: Schizophrenia - Aging Location: San Diego, CA
- Gamma-Amino Butyric Acid (GABA) Deficits and Vulnerability to Cannabinoid-Induced Psychosis - NCT00982982-06516
Conditions: Schizophrenia - Mental Disorders - Psychotic Disorders Location: West Haven, CT
- Genetic Study of Schizophrenia - NCT00001486-20892
Conditions: Psychotic Disorder - Schizoaffective Disorder - Schizophrenia Location: Bethesda, MD
- Glycine vs Placebo for the Schizophrenia Prodrome - NCT00291226-06519
Conditions: Schizophrenia Prodrome Location: New Haven, CT
- Graduated Recovery Intervention Program for Enhancing Treatment for First-Episode Psychosis - NCT00307216-27514
Conditions: Psychotic Disorders - Schizophrenia Location: Chapel Hill, NC
- High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder - NCT00297947-10035
Conditions: Schizophrenia - Schizoaffective Disorder Location: New York, NY
- High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder - NCT00297947-10962
Conditions: Schizophrenia - Schizoaffective Disorder Location: Orangeburg, NY
- High-Dose Oral Ziprasidone Versus Conventional Dosing in Schizophrenia Patients With Residual Symptoms - NCT00403546-02720
Conditions: Schizophrenia Location: Fall River, MA
- High-Dose Oral Ziprasidone Versus Conventional Dosing in Schizophrenia Patients With Residual Symptoms - NCT00403546-10032
Conditions: Schizophrenia Location: New York, NY
- High-Dose Oral Ziprasidone Versus Conventional Dosing in Schizophrenia Patients With Residual Symptoms - NCT00403546-10962
Conditions: Schizophrenia Location: Orangeburg, NY
- High-Dose Oral Ziprasidone Versus Conventional Dosing in Schizophrenia Patients With Residual Symptoms - NCT00403546-11203
Conditions: Schizophrenia Location: Brooklyn, NY
- High-Dose Oral Ziprasidone Versus Conventional Dosing in Schizophrenia Patients With Residual Symptoms - NCT00403546-27509
Conditions: Schizophrenia Location: Butner, NC
- High-Dose Oral Ziprasidone Versus Conventional Dosing in Schizophrenia Patients With Residual Symptoms - NCT00403546-30912
Conditions: Schizophrenia Location: Augusta, GA
- High-Dose Oral Ziprasidone Versus Conventional Dosing in Schizophrenia Patients With Residual Symptoms - NCT00403546-49503
Conditions: Schizophrenia Location: Grand Rapids, MI
- High-Dose Oral Ziprasidone Versus Conventional Dosing in Schizophrenia Patients With Residual Symptoms - NCT00403546-75024
Conditions: Schizophrenia Location: Plano, TX
- High-Dose Oral Ziprasidone Versus Conventional Dosing in Schizophrenia Patients With Residual Symptoms - NCT00403546-87131
Conditions: Schizophrenia Location: Albuquerque, NM
- Huperzine for Cognitive and Functional Impairment in Schizophrenia - NCT00963846-06519
Conditions: Schizophrenia Location: New Haven, CT
- Huperzine-A to Help With Mental Problems and the Inability to Care for Onself in Patients With Schizophrenia - NCT01012830-68105
Conditions: Schizophrenia - Dementia Location: Omaha, NE
- Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia - NCT00406718-78207
Conditions: Schizophrenia - Schizoaffective Disorder Location: San Antonio, TX
- Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors - NCT00178932-37212
Conditions: Schizophrenia - Schizoaffective Disorder - Bipolar Disorder - Major Depression Location: Nashville, TN
- Improving Representative Payeeship for People With Psychiatric Disabilities and Their Families - NCT00924976-27599
Conditions: Schizophrenia - Bipolar Disorder - Major Depressive Disorder Location: Chapel Hill, NC
- Influence of Nicotine on Cognitive Function in Schizophrenic Patients With and Without Comorbid Drug Dependence - NCT00686153-21228
Conditions: Schizophrenia - Substance Dependence - Smoking Location: Baltimore, MD
- Inpatient Evaluation of Adults With Schizophrenia - NCT00001247-20892
Conditions: Psychotic Disorder - Schizophrenia - Schizoaffective - Paranoia - Psychosis Location: Bethesda, MD
- Internal Monitoring of Eye Movement in Schizophrenia - NCT01011101-20892
Conditions: Schizophrenia Location: Bethesda, MD
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-
Conditions: Schizophrenia Location: National City, CA
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00706654-
Conditions: Schizophrenia Location: Garden Grove, CA
- Lifestyle Modification for Weight Loss in Schizophrenia - NCT00990925-06519
Conditions: Obesity - Schizophrenia - Schizoaffective Disorder Location: New Haven, CT
- Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia - NCT00615433-08046
Conditions: Schizophrenia Location: Willingboro, NJ
- Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia - NCT00615433-11516
Conditions: Schizophrenia Location: Cedarhurst, NY
- Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia - NCT00615433-27603
Conditions: Schizophrenia Location: Raleigh, NC
- Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia - NCT00615433-32751
Conditions: Schizophrenia Location: Maitland, FL
- Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia - NCT00615433-33180
Conditions: Schizophrenia Location: Aventura, FL
- Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia - NCT00615433-37212
Conditions: Schizophrenia Location: Nashville, TN
- Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia - NCT00615433-39232
Conditions: Schizophrenia Location: Flowood, MS
- Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia - NCT00615433-60640
Conditions: Schizophrenia Location: Chicago, IL
- Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia - NCT00615433-63118
Conditions: Schizophrenia Location: St. Louis, MO
- Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia - NCT00615433-71101
Conditions: Schizophrenia Location: Shreveport, LA
- Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia - NCT00615433-72211
Conditions: Schizophrenia Location: Little Rock, AR
- Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia - NCT00615433-77008
Conditions: Schizophrenia Location: Houston, TX
- Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia - NCT00615433-78754
Conditions: Schizophrenia Location: Austin, TX
- Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia - NCT00615433-90502
Conditions: Schizophrenia Location: Torrance, CA
- Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia - NCT00615433-90703
Conditions: Schizophrenia Location: Cerritos, CA
- Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia - NCT00615433-92056
Conditions: Schizophrenia Location: Oceanside, CA
- Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia - NCT00615433-92103
Conditions: Schizophrenia Location: San Diego, CA
- Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia - NCT00615433-92126
Conditions: Schizophrenia Location: San Diego, CA
- Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia - NCT00615433-92865
Conditions: Schizophrenia Location: Paramount, CA
- Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia - NCT00615433-92868
Conditions: Schizophrenia Location: Orange, CA
- Magnetic Resonance Imaging (MRI) of Neuropsychiatric Patients and Healthy Volunteers - NCT00001284-20892
Conditions: Healthy - Mental Disorder - Parkinson's Disease - Schizophrenia Location: Bethesda, MD
- Magnetic Resonance Imaging (MRI) of Neuropsychiatric Patients and Healthy Volunteers - NCT00004571-20892
Conditions: Bipolar Disorder - Healthy - Mood Disorder - Parkinson's Disease - Schizophrenia Location: Bethesda, MD
- Measuring Smoking Behavior in People With Schizophrenia and Bipolar Disorder - NCT00382915-08901
Conditions: Schizophrenia - Bipolar Disorder Location: New Brunswick, NJ
- Mindfulness Meditation as a Rehabilitation Strategy for Persons With Schizophrenia - NCT00936351-46202
Conditions: Schizophrenia - Schizoaffective Disorder - Psychotic Disorders Location: Indianapolis, IN
- Modafinil Augmentation in Chronic Schizophrenia and Schizoaffective Disorder - NCT00838227-10605
Conditions: Schizophrenia - Cognition - Obesity - Sedation Location: New York, NY
- Modafinil for Treatment of Cognitive Dysfunction in Schizophrenia - NCT00423943-95817
Conditions: Schizophrenia - Schizoaffective Disorder Location: Sacramento, CA
- Molecular Genetics of Schizophrenia - NCT00006418-10029
Conditions: Schizophrenia Location: New York, NY
- Molecular Genetics of Schizophrenia - NCT00006418-19104
Conditions: Schizophrenia Location: Philadelphia, PA
- Molecular Genetics of Schizophrenia - NCT00006418-30322
Conditions: Schizophrenia Location: Atlanta, GA
- Molecular Genetics of Schizophrenia - NCT00006418-52242
Conditions: Schizophrenia Location: Iowa City, IA
- Molecular Genetics of Schizophrenia - NCT00006418-60201
Conditions: Schizophrenia Location: Evanston, IL
- Molecular Genetics of Schizophrenia - NCT00006418-63128
Conditions: Schizophrenia Location: St. Louis, MO
- Molecular Genetics of Schizophrenia - NCT00006418-70112
Conditions: Schizophrenia Location: New Orleans, LA
- Molecular Genetics of Schizophrenia - NCT00006418-80262
Conditions: Schizophrenia Location: Denver, CO
- Molecular Genetics of Schizophrenia - NCT00006418-92697
Conditions: Schizophrenia Location: Irvine, CA
- Neurophysiological Targets for Cognitive Training in Schizophrenia - NCT00923078-06516
Conditions: Schizophrenia Location: West Haven, CT
- Nicotinic Receptors and Schizophrenia - NCT00952393-80220
Conditions: Schizophrenia Location: Denver, CO
- Oculomotor and Spatial Cognition Deficits in Schizophrenia - NCT00931996-60612
Conditions: Schizophrenia Location: Chicago, IL
- Once Weekly D-cycloserine for Schizophrenia - NCT00964041-02114
Conditions: Schizophrenia Location: Boston, MA
- Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia. - NCT00488319-
Conditions: Schizophrenia - Schizophrenic Disorders - Psychotic Disorders - Dementia Praecox. Location: Portsmouth, VA
- Optimizing Response in Psychosis Study - NCT00314327-11004
Conditions: Schizophrenia - Schizoaffective Disorder - Schizophreniform Disorder - Psychotic Disorder Not Otherwise Specified Location: Glen Oaks, NY
- Optimizing Response in Psychosis Study - NCT00314327-11203
Conditions: Schizophrenia - Schizoaffective Disorder - Schizophreniform Disorder - Psychotic Disorder Not Otherwise Specified Location: Brooklyn, NY
- Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia - NCT00330551-90095
Conditions: Schizophrenia Location: Los Angeles, CA
- Oxytocin and Social Cognition in Schizophrenia - NCT00884897-21228
Conditions: Social Cognition - Social Anxiety - Emotional Intelligence Location: Catonsville, MD
- Oxytocin or 3-[(2,4-Dimethoxy) Benzylidene] Anabaseine (DMXB-A) Versus Placebo for the Treatment of Negative Symptoms and Cognitive Impairments in Schizophrenia - NCT01012167-21201A
Conditions: Schizophrenia Location: Baltimore, MD
- Oxytocin or 3-[(2,4-Dimethoxy) Benzylidene] Anabaseine (DMXB-A) Versus Placebo for the Treatment of Negative Symptoms and Cognitive Impairments in Schizophrenia - NCT01012167-21201B
Conditions: Schizophrenia Location: Baltimore, MD
- Oxytocin or 3-[(2,4-Dimethoxy) Benzylidene] Anabaseine (DMXB-A) Versus Placebo for the Treatment of Negative Symptoms and Cognitive Impairments in Schizophrenia - NCT01012167-21222A
Conditions: Schizophrenia Location: Baltimore, MD
- Oxytocin or 3-[(2,4-Dimethoxy) Benzylidene] Anabaseine (DMXB-A) Versus Placebo for the Treatment of Negative Symptoms and Cognitive Impairments in Schizophrenia - NCT01012167-21222B
Conditions: Schizophrenia Location: Dundalk, MD
|
|
|
|
|
Didn't find what you were looking for? Try these alternatives:
Become A Member: To be notified of upcoming clinical trials in your
area please create a free member account.
Browse Studies: If you would like to browse all featured clinical trials
please Browse Studies.
Message Board: Join the discussion in our Health
and Clinical Trials Message Board.
|
|
|